This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Conference 2024 - Rare Disease Summit
March 18-20, 2025
Pre-Conference Workshops on March 17, 2025Sheraton Philadelphia Downtown | Philadelphia, PA
Menu

Kitty Colletti
Vice President, Sales at Mirum Pharmaceuticals
Speaker

Profile

Kitty Colletti joined Mirum in 2021 and currently serves as Vice President, Sales. With nearly 25 years of experience in the industry, Kitty has led the design, development, and execution of national commercial strategies for rare diseases and specialty therapeutics. Kitty leverages her clinical background in nursing to help guide companies from clinical to commercial stage and has specific expertise in driving early commercial planning and launch excellence within highly scientific therapeutic areas.

Prior to Mirum, Kitty served as Vice President, Sales, Sales Training and Access Solutions at Greenwich Biosciences (currently Jazz Pharmaceuticals). Before Greenwich, she led Managed Markets and the Cystic Fibrosis Business Unit at Allergan. From 2002-2014, Kitty was a pivotal member of the global sales leadership team at Aptalis Pharma (now AbbVie). Earlier in her career, she served as a Registered Nurse at Scripps Health.

Kitty has a BS in Nursing from San Diego State University.

Agenda Sessions

  • Valuable Insights into Lessons Learned for Launching Rare Disease Products

    , 2:00pm
    View Session

At this event

Prev
Next
Patrick Collins
Vice President, Corporate Relations
NORD

See Kitty at Rare Disease Conference 2024 - Rare Disease Summit